Neurological effects of ketamine: mechanisms, addiction potential, and toxicity profiles with focus on Saudi Arabia
Alanoud K. Albanna, Zayed M. Alnefaie, Atheer M. Saleh, Fatimah H. Alsayedeash, Layan S. Almejmaj, Afnan I. Alturki, Rawan K. Alnwagha, Fay N. Abu Deraa, Narjes Al Sabaa, Ahmed A. Obaid, Mazen Alayidh
International Journal of Community Medicine and Public Health July 17, 2025 DOI: 10.18203/2394-6040.ijcmph20252181 via OpenAlex
Summary
AI-generated from the abstractKetamine is used in anesthesia and mental health treatment for its rapid action and dissociative properties. It preserves stable vital signs during sedation and analgesia. Its influence on NMDA receptors and neurochemical systems is linked to antidepressant effects, especially for treatment-resistant depression. However, recreational abuse causes structural brain degeneration in areas related to memory, emotion, and motor control. In controlled settings, ketamine shows potential for addiction treatment by decreasing cravings and increasing abstinence rates. Toxicity risks include hallucinations, heart problems, urinary difficulties, and liver damage, especially with large or unsupervised doses. Cognitive impairment and psychiatric symptoms occur with prolonged use. Strict clinical supervision is needed.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Addiction Anxiety Ketamine |
| Keywords | Neurochemical Medicine Antidepressant |
| Key finding | Ketamine shows potential for addiction treatment by decreasing cravings and increasing abstinence rates, but chronic misuse causes structural brain degeneration and toxicity risks. |
Abstract
Ketamine’s rapid action and diverse physiological effects have made it an important drug in both anesthesia and mental health treatment. Clinically, it offers unique dissociative anesthetic properties, preserving stable vital signs during sedation and analgesia. Beyond its numbing effect, studies explore its influence on N-methyl-D-aspartate (NMDA) receptors and wider neurochemical systems linked to its antidepressant action, especially for treatment-resistant depression. While beneficial therapeutically, ketamine’s potential for abuse, especially recreationally, is a concern. Brain imaging reveals structural degeneration in brain areas related to memory, emotion, and motor control, due to chronic misuse, resulting in severe neurological changes. Yet, in controlled settings, ketamine displays potential for addiction treatment, as studies reveal decreased cravings and higher abstinence rates, Toxicity is a worry, particularly when ketamine is taken in large quantities or without medical guidance. Potential effects range from hallucinations and heart problems to difficulties with urination and liver damage. Cognitive impairment and psychiatric symptoms are also seen with prolonged use. While generally safe when used as directed, continued research emphasizes the need for strict clinical supervision and further investigation of its long-term consequences.